{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T18:03:39Z","timestamp":1789236219779,"version":"build-2803163510"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,1,2]],"date-time":"2021-01-02T00:00:00Z","timestamp":1609545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,2]],"date-time":"2021-01-02T00:00:00Z","timestamp":1609545600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100012283","name":"Chiayi Chang Gung Memorial Hospital","doi-asserted-by":"publisher","award":["CLRPG6G0042"],"award-info":[{"award-number":["CLRPG6G0042"]}],"id":[{"id":"10.13039\/501100012283","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Child Adolesc Psychiatry"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1007\/s00787-020-01694-2","type":"journal-article","created":{"date-parts":[[2021,1,2]],"date-time":"2021-01-02T20:02:39Z","timestamp":1609617759000},"page":"361-368","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Methylphenidate and TBI in ADHD and co-occurring epilepsy and mental disorders: a self-controlled case series study"],"prefix":"10.1007","volume":"31","author":[{"given":"Vincent Chin-Hung","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao-Hsu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles Tzu-Chi","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2934-5814","authenticated-orcid":false,"given":"Yi-Lung","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael E.","family":"Dewey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Gossop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,2]]},"reference":[{"issue":"4","key":"1694_CR1","doi-asserted-by":"publisher","first-page":"e994","DOI":"10.1542\/peds.2014-3482","volume":"135","author":"R Thomas","year":"2015","unstructured":"Thomas R, Sanders S, Doust J, Beller E, Glasziou P (2015) Prevalence of attention-deficit\/hyperactivity disorder: a systematic review and meta-analysis. Pediatrics 135(4):e994-1001. https:\/\/doi.org\/10.1542\/peds.2014-3482","journal-title":"Pediatrics"},{"issue":"10","key":"1694_CR2","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1016\/j.jaac.2016.06.016","volume":"55","author":"HE Erskine","year":"2016","unstructured":"Erskine HE, Norman RE, Ferrari AJ, Chan GC, Copeland WE, Whiteford HA, Scott JG (2016) Long-term outcomes of attention-deficit\/hyperactivity disorder and conduct disorder: a systematic review and meta-analysis. J Am Acad Child Adolesc Psychiatr 55(10):841\u2013850. https:\/\/doi.org\/10.1016\/j.jaac.2016.06.016","journal-title":"J Am Acad Child Adolesc Psychiatr"},{"issue":"3","key":"1694_CR3","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1001\/jamapsychiatry.2013.4174","volume":"71","author":"Z Chang","year":"2014","unstructured":"Chang Z, Lichtenstein P, D\u2019Onofrio BM, Sjolander A, Larsson H (2014) Serious transport accidents in adults with attention-deficit\/hyperactivity disorder and the effect of medication: a population-based study. JAMA Psychiatr 71(3):319\u2013325. https:\/\/doi.org\/10.1001\/jamapsychiatry.2013.4174","journal-title":"JAMA Psychiatr"},{"issue":"5","key":"1694_CR4","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.biopsych.2019.04.009","volume":"86","author":"Z Chang","year":"2019","unstructured":"Chang Z, Ghirardi L, Quinn PD, Asherson P, D\u2019Onofrio BM, Larsson H (2019) Risks and benefits of attention-deficit\/hyperactivity disorder medication on behavioral and neuropsychiatric outcomes: a qualitative review of pharmacoepidemiology studies using linked prescription databases. Biol Psychiatr 86(5):335\u2013343. https:\/\/doi.org\/10.1016\/j.biopsych.2019.04.009","journal-title":"Biol Psychiatr"},{"key":"1694_CR5","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.neubiorev.2017.11.007","volume":"84","author":"M Ruiz-Goikoetxea","year":"2018","unstructured":"Ruiz-Goikoetxea M, Cortese S, Aznarez-Sanado M, Magallon S, Alvarez Zallo N, Luis EO, de Castro-Manglano P, Soutullo C, Arrondo G (2018) Risk of unintentional injuries in children and adolescents with ADHD and the impact of ADHD medications: a systematic review and meta-analysis. Neurosci Biobehav Rev 84:63\u201371. https:\/\/doi.org\/10.1016\/j.neubiorev.2017.11.007","journal-title":"Neurosci Biobehav Rev"},{"issue":"8","key":"1694_CR6","doi-asserted-by":"publisher","first-page":"e198714","DOI":"10.1001\/jamanetworkopen.2019.8714","volume":"2","author":"VC Chen","year":"2019","unstructured":"Chen VC, Chan HL, Wu SI, Lee M, Lu ML, Liang HY, Dewey ME, Stewart R, Lee CT (2019) Attention-deficit\/hyperactivity disorder and mortality risk in Taiwan. JAMA Netw Open 2(8):e198714. https:\/\/doi.org\/10.1001\/jamanetworkopen.2019.8714","journal-title":"JAMA Netw Open"},{"issue":"11","key":"1694_CR7","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1111\/dmcn.12509","volume":"56","author":"J Cairney","year":"2014","unstructured":"Cairney J (2014) Deficits in attention, motor control, and perception and increased risk of injury in children. Dev Med Child Neurol 56(11):1040\u20131041. https:\/\/doi.org\/10.1111\/dmcn.12509","journal-title":"Dev Med Child Neurol"},{"issue":"2","key":"1694_CR8","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1093\/jpepsy\/jsh015","volume":"29","author":"R Rowe","year":"2004","unstructured":"Rowe R, Maughan B, Goodman R (2004) Childhood psychiatric disorder and unintentional injury: findings from a national cohort study. J Pediatr Psychol 29(2):119\u2013130. https:\/\/doi.org\/10.1093\/jpepsy\/jsh015","journal-title":"J Pediatr Psychol"},{"issue":"3","key":"1694_CR9","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1016\/j.ridd.2012.11.027","volume":"34","author":"YM Tai","year":"2013","unstructured":"Tai YM, Gau SS, Gau CS (2013) Injury-proneness of youth with attention-deficit hyperactivity disorder: a national clinical data analysis in Taiwan. Res Dev Disabil 34(3):1100\u20131108. https:\/\/doi.org\/10.1016\/j.ridd.2012.11.027","journal-title":"Res Dev Disabil"},{"key":"1694_CR10","doi-asserted-by":"publisher","unstructured":"Wolraich ML, Hagan JF Jr., Allan C, Chan E, Davison D, Earls M, Evans SW, Flinn SK, Froehlich T, Frost J, Holbrook JR, Lehmann CU, Lessin HR, Okechukwu K, Pierce KL, Winner JD, Zurhellen W, Subcommittee On C, Adolescents With Attention-Deficit\/Hyperactive D (2019) Clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit\/hyperactivity disorder in children and adolescents. Pediatrics 144 (4). doi:https:\/\/doi.org\/10.1542\/peds.2019-2528","DOI":"10.1542\/peds.2019-2528"},{"issue":"7","key":"1694_CR11","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1097\/chi.0b013e318054e724","volume":"46","author":"S Pliszka","year":"2007","unstructured":"Pliszka S, Issues AWGoQ (2007) Practice parameter for the assessment and treatment of children and adolescents with attention-deficit\/hyperactivity disorder. J Am Acad Child Adolesc Psychiatr 46(7):894\u2013921. https:\/\/doi.org\/10.1097\/chi.0b013e318054e724","journal-title":"J Am Acad Child Adolesc Psychiatr"},{"issue":"4","key":"1694_CR12","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1016\/j.chc.2012.07.005","volume":"21","author":"B Vaughan","year":"2012","unstructured":"Vaughan B, Kratochvil CJ (2012) Pharmacotherapy of pediatric attention-deficit\/hyperactivity disorder. Child Adolesc Psychiatr Clin N Am 21(4):941\u2013955. https:\/\/doi.org\/10.1016\/j.chc.2012.07.005","journal-title":"Child Adolesc Psychiatr Clin N Am"},{"issue":"10","key":"1694_CR13","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1016\/S2215-0366(18)30293-1","volume":"5","author":"SR Raman","year":"2018","unstructured":"Raman SR, Man KKC, Bahmanyar S, Berard A, Bilder S, Boukhris T, Bushnell G, Crystal S, Furu K, KaoYang YH, Karlstad O, Kieler H, Kubota K, Lai EC, Martikainen JE, Maura G, Moore N, Montero D, Nakamura H, Neumann A, Pate V, Pottegard A, Pratt NL, Roughead EE, Macias Saint-Gerons D, Sturmer T, Su CC, Zoega H, Sturkenbroom M, Chan EW, Coghill D, Ip P, Wong ICK (2018) Trends in attention-deficit hyperactivity disorder medication use: a retrospective observational study using population-based databases. Lancet Psychiatr 5(10):824\u2013835. https:\/\/doi.org\/10.1016\/S2215-0366(18)30293-1","journal-title":"Lancet Psychiatr"},{"issue":"3","key":"1694_CR14","doi-asserted-by":"publisher","first-page":"e0173762","DOI":"10.1371\/journal.pone.0173762","volume":"12","author":"VC Chen","year":"2017","unstructured":"Chen VC, Yang YH, Liao YT, Kuo TY, Liang HY, Huang KY, Huang YC, Lee Y, McIntyre RS, Lin TC (2017) The association between methylphenidate treatment and the risk for fracture among young ADHD patients: a nationwide population-based study in Taiwan. PLoS ONE 12(3):e0173762. https:\/\/doi.org\/10.1371\/journal.pone.0173762","journal-title":"PLoS ONE"},{"issue":"6","key":"1694_CR15","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1001\/jamapsychiatry.2017.0659","volume":"74","author":"Z Chang","year":"2017","unstructured":"Chang Z, Quinn PD, Hur K, Gibbons RD, Sjolander A, Larsson H, D\u2019Onofrio BM (2017) Association Between Medication Use for Attention-Deficit\/Hyperactivity Disorder and Risk of Motor Vehicle Crashes. JAMA Psychiatry 74(6):597\u2013603. https:\/\/doi.org\/10.1001\/jamapsychiatry.2017.0659","journal-title":"JAMA Psychiatry"},{"issue":"12","key":"1694_CR16","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1007\/s40263-017-0485-1","volume":"31","author":"KKC Man","year":"2017","unstructured":"Man KKC, Ip P, Chan EW, Law SL, Leung MTY, Ma EXY, Quek WT, Wong ICK (2017) Effectiveness of pharmacological treatment for attention-deficit\/hyperactivity disorder on physical injuries: a systematic review and meta-analysis of observational studies. CNS Drugs 31(12):1043\u20131055. https:\/\/doi.org\/10.1007\/s40263-017-0485-1","journal-title":"CNS Drugs"},{"key":"1694_CR17","doi-asserted-by":"publisher","unstructured":"Dewan MC, Rattani A, Gupta S, Baticulon RE, Hung YC, Punchak M, Agrawal A, Adeleye AO, Shrime MG, Rubiano AM, Rosenfeld JV, Park KB (2018) Estimating the global incidence of traumatic brain injury. J Neurosurg pp. 1\u201318. doi:https:\/\/doi.org\/10.3171\/2017.10.JNS17352","DOI":"10.3171\/2017.10.JNS17352"},{"key":"1694_CR18","doi-asserted-by":"publisher","unstructured":"Chang HK, Hsu JW, Wu JC, Huang KL, Chang HC, Bai YM, Chen TJ, Chen MH (2018) Traumatic brain injury in early childhood and risk of attention-deficit\/hyperactivity disorder and autism spectrum disorder: a nationwide longitudinal study. J Clin Psychiatr 79 (6). doi:https:\/\/doi.org\/10.4088\/JCP.17m11857","DOI":"10.4088\/JCP.17m11857"},{"issue":"5","key":"1694_CR19","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1001\/jamapediatrics.2017.5746","volume":"172","author":"ME Narad","year":"2018","unstructured":"Narad ME, Kennelly M, Zhang N, Wade SL, Yeates KO, Taylor HG, Epstein JN, Kurowski BG (2018) Secondary attention-deficit\/hyperactivity disorder in children and adolescents 5 to 10 years after traumatic brain injury. JAMA Pediatr 172(5):437\u2013443. https:\/\/doi.org\/10.1001\/jamapediatrics.2017.5746","journal-title":"JAMA Pediatr"},{"issue":"2","key":"1694_CR20","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.jadohealth.2018.02.012","volume":"63","author":"YJ Liou","year":"2018","unstructured":"Liou YJ, Wei HT, Chen MH, Hsu JW, Huang KL, Bai YM, Su TP, Li CT, Yang AC, Tsai SJ, Lin WC, Chen TJ (2018) Risk of traumatic brain injury among children, adolescents, and young adults with attention-deficit hyperactivity disorder in Taiwan. J Adolesc Health 63(2):233\u2013238. https:\/\/doi.org\/10.1016\/j.jadohealth.2018.02.012","journal-title":"J Adolesc Health"},{"key":"1694_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaac.2019.06.010","author":"L Ghirardi","year":"2019","unstructured":"Ghirardi L, Larsson H, Chang Z, Chen Q, Quinn PD, Hur K, Gibbons RD, D\u2019Onofrio BM (2019) Attention-deficit\/hyperactivity disorder medication and unintentional injuries in children and adolescents. J Am Acad Child Adolesc Psychiatr. https:\/\/doi.org\/10.1016\/j.jaac.2019.06.010","journal-title":"J Am Acad Child Adolesc Psychiatr"},{"issue":"3","key":"1694_CR22","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s00787-017-1042-7","volume":"27","author":"YT Liao","year":"2018","unstructured":"Liao YT, Yang YH, Kuo TY, Liang HY, Huang KY, Wang TN, Lee Y, McIntyre RS, Chen VC (2018) Dosage of methylphenidate and traumatic brain injury in ADHD: a population-based study in Taiwan. Eur Child Adolesc Psychiatr 27(3):279\u2013288. https:\/\/doi.org\/10.1007\/s00787-017-1042-7","journal-title":"Eur Child Adolesc Psychiatr"},{"issue":"2","key":"1694_CR23","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1111\/epi.14640","volume":"60","author":"I Brikell","year":"2019","unstructured":"Brikell I, Chen Q, Kuja-Halkola R, D\u2019Onofrio BM, Wiggs KK, Lichtenstein P, Almqvist C, Quinn PD, Chang Z, Larsson H (2019) Medication treatment for attention-deficit\/hyperactivity disorder and the risk of acute seizures in individuals with epilepsy. Epilepsia 60(2):284\u2013293. https:\/\/doi.org\/10.1111\/epi.14640","journal-title":"Epilepsia"},{"issue":"1","key":"1694_CR24","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1177\/0883073812440327","volume":"28","author":"R Cohen","year":"2013","unstructured":"Cohen R, Senecky Y, Shuper A, Inbar D, Chodick G, Shalev V, Raz R (2013) Prevalence of epilepsy and attention-deficit hyperactivity (ADHD) disorder: a population-based study. J Child Neurol 28(1):120\u2013123. https:\/\/doi.org\/10.1177\/0883073812440327","journal-title":"J Child Neurol"},{"issue":"1","key":"1694_CR25","first-page":"50","volume":"25","author":"M Ravi","year":"2016","unstructured":"Ravi M, Ickowicz A (2016) Epilepsy, attention-deficit\/hyperactivity disorder and methylphenidate: Critical examination of guiding evidence. J Can Acad Child Adolesc Psychiatr 25(1):50\u201358","journal-title":"J Can Acad Child Adolesc Psychiatr"},{"key":"1694_CR26","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.seizure.2019.06.013","volume":"71","author":"C Jory","year":"2019","unstructured":"Jory C, Oak K, Organ C, McLean B, Shankar R (2019) Head first: review of epilepsy head injury risk and protection. Seizure 71:66\u201379. https:\/\/doi.org\/10.1016\/j.seizure.2019.06.013","journal-title":"Seizure"},{"issue":"11","key":"1694_CR27","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1001\/jamapsychiatry.2019.1944","volume":"76","author":"S Sun","year":"2019","unstructured":"Sun S, Kuja-Halkola R, Faraone SV, D\u2019Onofrio BM, Dalsgaard S, Chang Z, Larsson H (2019) Association of psychiatric comorbidity with the risk of premature death among children and adults with attention-deficit\/hyperactivity disorder. JAMA Psychiatr 76(11):1141\u20131149. https:\/\/doi.org\/10.1001\/jamapsychiatry.2019.1944","journal-title":"JAMA Psychiatr"},{"issue":"2","key":"1694_CR28","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1111\/jcpp.13136","volume":"61","author":"L Ghirardi","year":"2020","unstructured":"Ghirardi L, Chen Q, Chang Z, Kuja-Halkola R, Skoglund C, Quinn PD, D\u2019Onofrio BM, Larsson H (2020) Use of medication for attention-deficit\/hyperactivity disorder and risk of unintentional injuries in children and adolescents with co-occurring neurodevelopmental disorders. J Child Psychol Psychiatr 61(2):140\u2013147. https:\/\/doi.org\/10.1111\/jcpp.13136","journal-title":"J Child Psychol Psychiatr"},{"issue":"3","key":"1694_CR29","doi-asserted-by":"publisher","first-page":"382","DOI":"10.3109\/00048679709073848","volume":"31","author":"CH Ng","year":"1997","unstructured":"Ng CH (1997) The stigma of mental illness in Asian cultures. Aust N Z J Psychiatr 31(3):382\u2013390. https:\/\/doi.org\/10.3109\/00048679709073848","journal-title":"Aust N Z J Psychiatr"},{"key":"1694_CR30","doi-asserted-by":"publisher","first-page":"349","DOI":"10.2147\/CLEP.S196293","volume":"11","author":"CY Hsieh","year":"2019","unstructured":"Hsieh CY, Su CC, Shao SC, Sung SF, Lin SJ, Kao Yang YH, Lai EC (2019) Taiwan\u2019s National Health Insurance Research Database: past and future. Clin Epidemiol 11:349\u2013358. https:\/\/doi.org\/10.2147\/CLEP.S196293","journal-title":"Clin Epidemiol"},{"key":"1694_CR31","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.jad.2015.09.015","volume":"189","author":"M-J Lee","year":"2016","unstructured":"Lee M-J, Yang K-C, Shyu Y-C, Yuan S-S, Yang C-J, Lee S-Y, Lee T-L, Wang L-J (2016) Attention-deficit hyperactivity disorder, its treatment with medication and the probability of developing a depressive disorder: a nationwide population-based study in Taiwan. J Affect Disord 189:110\u2013117. https:\/\/doi.org\/10.1016\/j.jad.2015.09.015","journal-title":"J Affect Disord"},{"key":"1694_CR32","doi-asserted-by":"publisher","first-page":"g3769","DOI":"10.1136\/bmj.g3769","volume":"348","author":"Q Chen","year":"2014","unstructured":"Chen Q, Sjolander A, Runeson B, D\u2019Onofrio BM, Lichtenstein P, Larsson H (2014) Drug treatment for attention-deficit\/hyperactivity disorder and suicidal behaviour: register based study. BMJ 348:g3769. https:\/\/doi.org\/10.1136\/bmj.g3769","journal-title":"BMJ"},{"issue":"12","key":"1694_CR33","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1016\/j.biopsych.2016.02.018","volume":"80","author":"Z Chang","year":"2016","unstructured":"Chang Z, D\u2019Onofrio BM, Quinn PD, Lichtenstein P, Larsson H (2016) Medication for attention-deficit\/hyperactivity disorder and risk for depression: a nationwide longitudinal cohort study. Biol Psychiatr 80(12):916\u2013922. https:\/\/doi.org\/10.1016\/j.biopsych.2016.02.018","journal-title":"Biol Psychiatr"},{"issue":"2","key":"1694_CR34","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1097\/JCP.0000000000000668","volume":"37","author":"A Kutlu","year":"2017","unstructured":"Kutlu A, Akyol Ardic U, Ercan ES (2017) Effect of methylphenidate on emotional dysregulation in children with attention-deficit\/hyperactivity disorder + oppositional defiant disorder\/conduct disorder. J Clin Psychopharmacol 37(2):220\u2013225. https:\/\/doi.org\/10.1097\/JCP.0000000000000668","journal-title":"J Clin Psychopharmacol"},{"issue":"5","key":"1694_CR35","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1097\/YIC.0000000000000175","volume":"32","author":"P Golubchik","year":"2017","unstructured":"Golubchik P, Rapaport M, Weizman A (2017) The effect of methylphenidate on anxiety and depression symptoms in patients with Asperger syndrome and comorbid attention deficit\/hyperactivity disorder. Int Clin Psychopharmacol 32(5):289\u2013293. https:\/\/doi.org\/10.1097\/YIC.0000000000000175","journal-title":"Int Clin Psychopharmacol"},{"issue":"5","key":"1694_CR36","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1097\/00004583-199705000-00008","volume":"36","author":"FX Castellanos","year":"1997","unstructured":"Castellanos FX, Giedd JN, Elia J, Marsh WL, Ritchie GF, Hamburger SD, Rapoport JL (1997) Controlled stimulant treatment of ADHD and comorbid Tourette\u2019s syndrome: effects of stimulant and dose. J Am Acad Child Adolesc Psychiatr 36(5):589\u2013596. https:\/\/doi.org\/10.1097\/00004583-199705000-00008","journal-title":"J Am Acad Child Adolesc Psychiatr"},{"issue":"12","key":"1694_CR37","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1001\/jama.1982.03320370043028","volume":"247","author":"TL Lowe","year":"1982","unstructured":"Lowe TL, Cohen DJ, Detlor J, Kremenitzer MW, Shaywitz BA (1982) Stimulant medications precipitate Tourette\u2019s syndrome. JAMA 247(12):1729\u20131731","journal-title":"JAMA"},{"issue":"9","key":"1694_CR38","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/j.jaac.2015.06.011","volume":"54","author":"SC Cohen","year":"2015","unstructured":"Cohen SC, Mulqueen JM, Ferracioli-Oda E, Stuckelman ZD, Coughlin CG, Leckman JF, Bloch MH (2015) Meta-analysis: risk of tics associated with psychostimulant use in randomized, placebo-controlled trials. J Am Acad Child Adolesc Psychiatr 54(9):728\u2013736. https:\/\/doi.org\/10.1016\/j.jaac.2015.06.011","journal-title":"J Am Acad Child Adolesc Psychiatr"},{"issue":"5","key":"1694_CR39","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1093\/oxfordjournals.aje.a115210","volume":"129","author":"DA Savitz","year":"1989","unstructured":"Savitz DA, Bar\u00f3n AE (1989) Estimating and correcting for confounder misclassification. Am J Epidemiol 129(5):1062\u20131071","journal-title":"Am J Epidemiol"}],"container-title":["European Child & Adolescent Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00787-020-01694-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00787-020-01694-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00787-020-01694-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,11]],"date-time":"2022-02-11T09:16:39Z","timestamp":1644570999000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00787-020-01694-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,2]]},"references-count":39,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["1694"],"URL":"https:\/\/doi.org\/10.1007\/s00787-020-01694-2","relation":{},"ISSN":["1018-8827","1435-165X"],"issn-type":[{"value":"1018-8827","type":"print"},{"value":"1435-165X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,2]]},"assertion":[{"value":"26 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Author Vincent Chin-Hung Chen has been an investigator in a clinical trial from Orient Pharma. The other report no competing interests related to this work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in the study involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. Informed consent was obtained from all individual participants included in the study. This article does not contain any studies with animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical statement"}}]}}